Literature DB >> 15378650

Differences in ornithine decarboxylase and androgen receptor allele frequencies among ethnic groups.

Thomas G O'Brien1, Y Guo, K Visvanathan, J Sciulli, M McLaine, K J Helzlsouer, D Watkins-Bruner.   

Abstract

Recent evidence suggests that the A allele of the ornithine decarboxylase (ODC) gene is a genetic risk factor for prostate cancer. ODC is a target gene of the highly polymorphic androgen receptor (AR) gene, short alleles of which have been associated in some studies with increased prostate cancer risk. We determined ODC allele frequencies and distribution of AR alleles in American Caucasians, African-Americans, Hispanics, Europeans, and Africans. The frequency of the ODC A allele varied from 0.183 (Hispanics, Europeans) to 0.415 (Africans) with American Caucasian and African-Americans having intermediate values. The mean number of CAG repeats in the AR gene varied from 19.8 (African-Americans) to 25.1 (Hispanics). It is possible that ethnic differences in risk alleles for ODC and AR may account for some of the ethnic variation in prostate cancer risk. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15378650     DOI: 10.1002/mc.20047

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  7 in total

Review 1.  Mammalian polyamine metabolism and function.

Authors:  Anthony E Pegg
Journal:  IUBMB Life       Date:  2009-09       Impact factor: 3.885

2.  Androgen receptor CAG repeat length and risk of biliary tract cancer and stones.

Authors:  Tamra E Meyer; Thomas G O'Brien; Gabriella Andreotti; Kai Yu; Qizhai Li; Yu-Tang Gao; Asif Rashid; Ming-Chang Shen; Bing-Sheng Wang; Tian-Quan Han; Bai-He Zhang; Shelley Niwa; Joseph F Fraumeni; Ann W Hsing
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-03-03       Impact factor: 4.254

3.  Involvement of different mechanisms for the association of CAG repeat length polymorphism in androgen receptor gene with prostate cancer.

Authors:  Xueying Mao; Jie Li; Xingxing Xu; Lara K Boyd; Weiyang He; Elzbieta Stankiewicz; Sakunthala C Kudahetti; Guangwen Cao; Daniel Berney; Guosheng Ren; Xin Gou; Hongwei Zhang; Yong-Jie Lu
Journal:  Am J Cancer Res       Date:  2014-11-19       Impact factor: 6.166

4.  Ornithine decarboxylase-1 polymorphism, chemoprevention with eflornithine and sulindac, and outcomes among colorectal adenoma patients.

Authors:  Jason A Zell; Christine E McLaren; Wen-Pin Chen; Patricia A Thompson; Eugene W Gerner; Frank L Meyskens
Journal:  J Natl Cancer Inst       Date:  2010-08-26       Impact factor: 13.506

5.  Ethnical disparities of prostate cancer predisposition: genetic polymorphisms in androgen-related genes.

Authors:  Jie Li; Emma Mercer; Xin Gou; Yong-Jie Lu
Journal:  Am J Cancer Res       Date:  2013-04-03       Impact factor: 6.166

6.  Associations of a polymorphism in the ornithine decarboxylase gene with colorectal cancer survival.

Authors:  Jason A Zell; Argyrios Ziogas; Natalia Ignatenko; Jane Honda; Ning Qu; Alexander S Bobbs; Susan L Neuhausen; Eugene W Gerner; Hoda Anton-Culver
Journal:  Clin Cancer Res       Date:  2009-09-29       Impact factor: 12.531

7.  The effect of difluoromethylornithine on decreasing prostate size and polyamines in men: results of a year-long phase IIb randomized placebo-controlled chemoprevention trial.

Authors:  Anne R Simoneau; Eugene W Gerner; Ray Nagle; Argyrios Ziogas; Sharon Fujikawa-Brooks; Hagit Yerushalmi; Thomas E Ahlering; Ronald Lieberman; Christine E McLaren; Hoda Anton-Culver; Frank L Meyskens
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-02       Impact factor: 4.254

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.